Efficacy of Nortriptyline and Migraine Lifestyle Modifications in Vestibular Migraine Management

Madelyn Frank,Karen Tawk,Ella J. Lee,Joshua K. Kim,Abdula Al‐Seraji,Mehdi Abouzari,Hamid R. Djalilian
DOI: https://doi.org/10.1111/coa.14231
IF: 2.729
2024-09-28
Clinical Otolaryngology
Abstract:Objective To evaluate the effectiveness of nortriptyline regimen and migraine dietary/lifestyle modifications on dizziness and stress levels in patients diagnosed with vestibular migraine (VM). Methods A total of 35 patients diagnosed with definite VM based on the International Classification of Headache Disorders were included in this intervention study. Patients self‐selected to receive either nortriptyline regimen alone (10–40 mg daily with biweekly escalation) (group A, n = 17) or migraine dietary/lifestyle modifications alone (group B, n = 18). Main outcome measures were dizziness severity and stress level measured by the visual analog scale (VAS). Results At 4‐week post‐treatment, dizziness decreased from 6.0 ± 2.5 to 4.2 ± 3.4 (p = 0.069) in group A and from 8.7 ± 1.5 to 3.6 ± 3.0 (p
otorhinolaryngology
What problem does this paper attempt to address?